In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Velcade, MG-341, PS-341, Bortezomib Drug Master File in Korea (Velcade, MG-341, PS-341, Bortezomib KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Velcade, MG-341, PS-341, Bortezomib. The MFDS reviews the Velcade, MG-341, PS-341, Bortezomib KDMF as part of the drug registration process and uses the information provided in the Velcade, MG-341, PS-341, Bortezomib KDMF to evaluate the safety and efficacy of the drug.
After submitting a Velcade, MG-341, PS-341, Bortezomib KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Velcade, MG-341, PS-341, Bortezomib API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Velcade, MG-341, PS-341, Bortezomib suppliers with KDMF on PharmaCompass.